Study improves detection of biomarkers to predict lung cancer
One of the biggest challenges in oncological medicine is to detect lung cancer earlier enough to allow treatment because now the location of these tumors implies a metastasis in about 75% of cases. This research has confirmed that the presence of a protein called C4d "is associated with a mortality increase of people whose tumors contain it, and also the levels of this marker are reduced after surgical removal of the cancer," said Carlos Camps, also a researcher of the University General Hospital of Valencia Research Foundation. This protein "may be a biomarker for early detection and treatment of lung cancer because it would diagnose those people at increased risk for this disease, but no symptoms," adds the scientist Eloisa Jantus- Lewintre, co-author of the work and belonging to General Hospital Foundation…